Ketamine in Bariatric Surgery

Effects of Ketamine on Recovery From Bariatric Surgery

Status

UNKNOWN

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01724983

Enrollment

Registered

2012-11-12

Start date

2012-06-30

Completion date

2014-06-30

Last updated

2012-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity

Keywords

pain, mood, depression, respiration

Brief summary

Ketamine may improve recovery from bariatric surgery.

Interventions

DRUGketamine

DRUGfentanyl

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* age \> 18 * obesity (Body Mass Index \> 30) * ASA classificazion \< 4 * candidate to bariatric surgery

Exclusion criteria

* known or presumed pregnancy * previous surgery on the airway, esophagus or stomach * uncontrolled psychiatric symptomatology

Design outcomes

Primary

Measure	Time frame
mood level	postoperatively, up to 3 months
pain level	postoperatively, up to 3 months

Secondary

Measure	Time frame
postanesthetic recovery	postoperatively, up to 24 hours
satisfaction of the patient and of the surgeon	day 1
vasoactive drugs	intraoperatively and up to 24 hours from surgery end
lung volumes	postoperatively, up to 48 hours from end of surgery
antihemetic drug dosage	postoperatively, up to 24 hours
pulse oximetry saturation	postoperatively, up to 24 hours
total dosages of analgesic and muscle relaxant drugs	postoperatively, up to 3 months

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026